The Gillett Health Podcast cover image

Sarms & GLP1's

The Gillett Health Podcast

00:00

Exploring Inobosarm and Semaglutide in Clinical Trials

This chapter focuses on the resurgence of Selective Androgen Receptor Modulators, particularly Inobosarm, and its implications for older adults with sarcopenic obesity. It highlights surprising mobility improvements in participants and discusses the benefits of semaglutide for body recomposition. Additionally, the chapter addresses safety concerns, market pathways, and personal experiences with performance enhancement substances.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app